Enzyme Immunoassay Market, By Product Type (Reagents & Kits, Instruments, and Software & Services), By Specimen, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4731
|
Published Date
February 2026
|
Pages
321
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Enzyme Immunoassay Market size was valued at USD 17,850.09 Million in 2024, expanding to a CAGR of 3.87% from 2025 to 2032.
Enzyme Immunoassay (EIA) is a biochemical analytical technique used to detect and quantify specific substances such as antigens, antibodies, hormones, proteins, or drugs by exploiting the high specificity of antigen–antibody interactions. In this method, an enzyme is chemically linked to an antibody or antigen and serves as a signal generator. When the target molecule binds to its corresponding antibody, the attached enzyme catalyzes a reaction with an added substrate, producing a measurable signal—typically a color change, fluorescence, or luminescence—that indicates the presence and concentration of the target substance. EIA technologies play a critical role in global public health and diagnostics, particularly in testing for infectious and chronic diseases. Government health initiatives and screening programs around the world rely on immunoassay technologies to support disease control and prevention; for example, enzyme immunoassays accounted for a dominant share of approximately 64% of the global immunoassay market in 2023, reflecting widespread government and clinical adoption for largescale testing.
Enzyme Immunoassay Market- Market Dynamics
Rising prevalence of chronic and infectious diseases, coupled with the expansion of diagnostic infrastructure, is expected to drive market demand
The rising incidence of infectious diseases such as HIV, hepatitis, tuberculosis, and newly emerging viral infections is a major driver of growth in the enzyme immunoassay (EIA) market. EIAs are widely used for early diagnosis, large-scale screening, and confirmatory testing, offering high accuracy, strong specificity, and cost-effective performance. Simultaneously, the increasing prevalence of chronic diseases—including cardiovascular conditions, cancer, autoimmune disorders, and diabetes—has heightened the need for reliable and efficient diagnostic solutions. Enzyme immunoassays are critical for detecting disease-specific biomarkers, hormones, and antibodies, enabling timely diagnosis and continuous monitoring of disease progression. With healthcare systems worldwide emphasizing preventive care, early detection, and improved patient outcomes, the use of EIA-based diagnostic tests is steadily expanding across hospitals, clinical laboratories, and diagnostic centers globally. According to World Health Organization (WHO) estimates, an estimated 10.7million people fell ill with tuberculosis worldwide in 2024, with TB remaining one of the leading infectious diseases requiring robust diagnostic surveillance and testing infrastructure.
Ongoing technological advancements in enzyme immunoassay platforms—including enhanced ELISA kits, greater automation, multiplex testing capabilities, and more efficient enzymes and substrates—are further supporting market growth. Automated and semi-automated EIA systems improve testing efficiency, reduce manual errors, and allow high-throughput analysis, making them particularly attractive to modern clinical laboratories. Additionally, the rapid expansion of healthcare and diagnostic infrastructure in emerging economies, driven by supportive government policies and increased private-sector investment, has broadened access to advanced diagnostic solutions. The growing application of enzyme immunoassays in pharmaceutical research, vaccine development, and clinical trials is also boosting market demand. Together, technological innovation and infrastructure development are accelerating the widespread adoption of enzyme immunoassays across clinical, research, and industrial settings worldwide.
Enzyme Immunoassay Market- Segmentation Analysis:
The Global Enzyme Immunoassay Market is segmented on the basis of Product Type, Specimen, Application, End User, and Region.
The blood segment dominates the global enzyme immunoassay (EIA) specimen market, owing to its high diagnostic reliability and broad clinical applicability. Blood-based samples provide elevated concentrations of biomarkers, including antigens, antibodies, hormones, and proteins, enabling enzyme immunoassays to achieve superior sensitivity and specificity compared to other specimen types. The widespread use of blood tests across hospitals, diagnostic laboratories, and research institutions further drives this segment’s revenue share. Globally, governments are prioritizing access to reliable diagnostic testing: for example, the World Health Organization (WHO) reports that over 190 countries include blood-based diagnostic testing as part of their essential healthcare services, emphasizing its role in early disease detection, monitoring, and public health initiatives.
Based on application, the infectious diseases segment accounted for the largest market share in 2024, driven by the persistently high global prevalence of infectious diseases. Conditions such as HIV/AIDS, hepatitis B and C, tuberculosis, influenza, and other viral and bacterial infections continue to impose significant public health challenges, particularly in densely populated and low- to middle-income regions. This sustained disease burden has fueled demand for accurate, rapid, and cost-effective diagnostic methods. Government and international public health programs further reinforce this growth: according to WHO, global funding for infectious disease diagnostics exceeded USD 15 billion in 2023, with initiatives in countries such as India, South Africa, and Brazil prioritizing laboratory expansion, rapid test deployment, and public health monitoring to control disease spread effectively.
Enzyme Immunoassay Market- Geographical Insights
Across the globe, the Enzyme Immunoassay (EIA) market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. North America accounts for a substantial share of the market, driven by its advanced laboratory infrastructure, high healthcare expenditure, early adoption of automated immunoassay technologies, and the strong presence of major diagnostic companies. In 2024, North America held nearly 39% of the global enzyme immunoassay market, reflecting the region’s leadership in diagnostic testing and technology uptake.
Europe follows, supported by robust public healthcare systems, widespread routine screening programs, and an increasing emphasis on early detection of infectious and chronic diseases—factors that have strengthened demand for immunoassay testing. The Asia Pacific region is the fastestgrowing market, propelled by expanding access to healthcare services, a rising disease burden, greater awareness of early diagnostic testing, and significant investments in laboratory infrastructure by both governments and private players, particularly in China and India. Latin America is experiencing steady growth due to ongoing improvements in healthcare infrastructure and increasing volumes of diagnostic testing across the region. Overall, public health initiatives, expanded screening programs, and governmentfunded diagnostic infrastructure projects worldwide continue to reinforce the adoption of enzyme immunoassays as essential tools for disease detection and monitoring.
Italy Enzyme Immunoassay Market- Key Insights
China stands out as a major country within the Asia Pacific enzyme immunoassay (EIA) market and represents one of the fastestexpanding national markets in this sector. Growth is fueled by its large population, rising incidence of infectious and chronic diseases, and increasing demand for timely and accurate diagnostic solutions. Governmentled efforts to strengthen public healthcare systems, broaden disease screening initiatives, and upgrade laboratory infrastructure have significantly accelerated the adoption of enzyme immunoassays in hospitals and diagnostic centers. China’s national health agenda, particularly the “Healthy China 2030” strategy, prioritizes disease prevention, chronic disease management, and improved healthcare services as part of broader public health reform efforts, reflecting sustained public investment in diagnostics and early detection.
Additionally, the rapid expansion of China’s biotechnology and pharmaceutical industries has boosted the use of EIAs in drug discovery, vaccine development, and clinical research. Increasing awareness of preventive healthcare and growing adoption of automated and highthroughput immunoassay technologies continue to support the longterm growth of the EIA market in China.
Enzyme Immunoassay Market- Competitive Landscape:
The enzyme immunoassay (EIA) market is highly competitive, featuring a mix of global healthcare conglomerates and specialized diagnostic companies striving to strengthen their market positions. Leading players such as Siemens Healthineers, Danaher Corporation, Bio-Rad Laboratories, bioMérieux SA, and QuidelOrtho maintain a competitive edge through extensive product portfolios, advanced immunoassay platforms, and well-established global distribution networks. These companies focus heavily on continuous innovation, offering automated and high-throughput enzyme immunoassay systems that enhance laboratory efficiency, accuracy, and turnaround times. Significant research and development investments enable them to regularly launch new and improved assay kits targeting infectious diseases, chronic conditions, and specialized diagnostic applications.
Recent Developments:
- In 2025, Revvity Inc. launched the IDS i20, a fully automated chemiluminescence immunoassay system that supports multi-specialty testing on a single platform, improving workflow efficiency in clinical laboratories.
- In February 2025, VION Biosciences acquired BioAssay Systems, a company specializing in high-throughput enzyme immunoassay technologies. This strategic acquisition expanded VION’s capabilities and footprint in the diagnostics and life sciences tools sector.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ENZYME IMMUNOASSAY MARKET KEY PLAYERS
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- F. Hoffmann-La Roche AG
- Abbott Laboratories
- Bio-Rad Laboratories
- bioMérieux SA
- QuidelOrtho Corporation
- Becton, Dickinson and Company
- Sysmex Corporation
- PerkinElmer (Revvity)
- Agilent Technologies
- Merck KGaA
- DiaSorin S.p.A.
- Randox Laboratories
- VION Biosciences
- Others
GLOBAL ENZYME IMMUNOASSAY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032
- Reagents & Kits
- Instruments
- Software & Services
GLOBAL ENZYME IMMUNOASSAY MARKET, BY SPECIMEN- MARKET ANALYSIS, 2019-2032
- Blood
- Urine
- Saliva
- Others
GLOBAL ENZYME IMMUNOASSAY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032
- Infectious diseases
- Cardiology
- Oncology
- Autoimmune disorders
- Therapeutic drug monitoring
- Others
GLOBAL ENZYME IMMUNOASSAY MARKET, BY END USER- MARKET ANALYSIS, 2019-2032
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotech Companies
- Academic Research
- Others
GLOBAL ENZYME IMMUNOASSAY MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Enzyme Immunoassay Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Enzyme Immunoassay Market Snippet by Product Type
2.1.2. Enzyme Immunoassay Market Snippet by Specimen
2.1.3. Enzyme Immunoassay Market Snippet by Application
2.1.4. Enzyme Immunoassay Market Snippet by End User
2.1.5. Enzyme Immunoassay Market Snippet by Country
2.1.6. Enzyme Immunoassay Market Snippet by Region
2.2. Competitive Insights
3. Enzyme Immunoassay Key Market Trends
3.1. Enzyme Immunoassay Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Enzyme Immunoassay Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Enzyme Immunoassay Market Opportunities
3.4. Enzyme Immunoassay Market Future Trends
4. Enzyme Immunoassay Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Enzyme Immunoassay Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Enzyme Immunoassay Market Landscape
6.1. Enzyme Immunoassay Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Enzyme Immunoassay Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Reagents & Kits
7.1.3. Instruments
7.1.4. Software & Services
8. Enzyme Immunoassay Market – By Specimen
8.1. Overview
8.1.1. Segment Share Analysis, By Specimen, 2024 & 2032 (%)
8.1.2. Blood
8.1.3. Urine
8.1.4. Saliva
8.1.5. Others
9. Enzyme Immunoassay Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Infectious diseases
9.1.3. Cardiology
9.1.4. Oncology
9.1.5. Autoimmune disorders
9.1.6. Therapeutic drug monitoring
9.1.7. Others
10. Enzyme Immunoassay Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By Specimen, 2024 & 2032 (%)
10.1.2. Hospitals
10.1.3. Diagnostic Laboratories
10.1.4. Pharmaceutical & Biotech Companies
10.1.5. Academic Research
10.1.6. Others
11. Enzyme Immunoassay Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Enzyme Immunoassay Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Enzyme Immunoassay Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Enzyme Immunoassay Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Enzyme Immunoassay Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Enzyme Immunoassay Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Enzyme Immunoassay Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Siemens Healthineers
12.2.2. Danaher Corporation
12.2.3. Thermo Fisher Scientific
12.2.4. F. Hoffmann-La Roche AG
12.2.5. Abbott Laboratories
12.2.6. Bio-Rad Laboratories
12.2.7. bioMérieux SA
12.2.8. QuidelOrtho Corporation
12.2.9. Becton, Dickinson and Company
12.2.10. Sysmex Corporation
12.2.11. PerkinElmer (Revvity)
12.2.12. Agilent Technologies
12.2.13. Merck KGaA
12.2.14. DiaSorin S.p.A.
12.2.15. Randox Laboratories
12.2.16. VION Biosciences
12.2.17. Others
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ENZYME IMMUNOASSAY MARKET KEY PLAYERS
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- F. Hoffmann-La Roche AG
- Abbott Laboratories
- Bio-Rad Laboratories
- bioMérieux SA
- QuidelOrtho Corporation
- Becton, Dickinson and Company
- Sysmex Corporation
- PerkinElmer (Revvity)
- Agilent Technologies
- Merck KGaA
- DiaSorin S.p.A.
- Randox Laboratories
- VION Biosciences
- Others
GLOBAL ENZYME IMMUNOASSAY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032
- Reagents & Kits
- Instruments
- Software & Services
GLOBAL ENZYME IMMUNOASSAY MARKET, BY SPECIMEN- MARKET ANALYSIS, 2019-2032
- Blood
- Urine
- Saliva
- Others
GLOBAL ENZYME IMMUNOASSAY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032
- Infectious diseases
- Cardiology
- Oncology
- Autoimmune disorders
- Therapeutic drug monitoring
- Others
GLOBAL ENZYME IMMUNOASSAY MARKET, BY END USER- MARKET ANALYSIS, 2019-2032
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotech Companies
- Academic Research
- Others
GLOBAL ENZYME IMMUNOASSAY MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
